Vijai Lakshmi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Vijai Lakshmi has a total of 61 co-authors. Here are the top co-authors by number of shared publications:
Shishir Srivastava
Central Drug Research Institute
4 shared publicationsSunil Kumar Mishra
Medicinal and Process Chemistry Division Central Drug Research Institute Lucknow 226 001 India
4 shared publicationsAnil K. Saxena
Central Drug Research Institute
3 shared publicationsGautam Palit
Division of Pharmacology, Central Drug Research Institute, Lucknow226001, UP, India
3 shared publicationsGitika Bhatia
King George Medical University
3 shared publicationsRajesh Kumar
Medicinal and Process Chemistry Division , Central Drug Research Institute , Chattar Manzil Palace, Lucknow-226001, India
3 shared publications
Latest Publications
- 2 September 2014
- Published by Taylor & Francis in Natural Product Research
- Vol. 29 (5) , 469-473
In vivogastroprotective effect of xyloccensin-E and xyloccensin-I fromXylocarpus molluccensisin rats
Anti-ulcer activities of xyloccensin-E and xyloccensin-I were investigated in various ulcer models in Sprague-Dawley rats. The effects and the mechanism of action of both compounds for anti-secretory and cytoprotective activities were also studied. Both these active molecules improved the depleted levels of mucin and consequently inhibited the formation of erosions in a pyloric ligated ulcer model. Furthermore, xyloccensin-E and xyloccensin-I inhibited H+K+-ATPase activity in vitro confirming their anti-secretory activity. In conclusion, xyloccensin-E and xyloccensin-I were found to possess anti-ulcerogenic activity which might be due to their anti-secretory activity and subsequent strengthening of the defensive mechanism.
- 2 September 2014
- Published by Taylor & Francis in Natural Product Research
- Vol. 29 (5) , 469-473
In vivogastroprotective effect of xyloccensin-E and xyloccensin-I fromXylocarpus molluccensisin rats
Anti-ulcer activities of xyloccensin-E and xyloccensin-I were investigated in various ulcer models in Sprague-Dawley rats. The effects and the mechanism of action of both compounds for anti-secretory and cytoprotective activities were also studied. Both these active molecules improved the depleted levels of mucin and consequently inhibited the formation of erosions in a pyloric ligated ulcer model. Furthermore, xyloccensin-E and xyloccensin-I inhibited H+K+-ATPase activity in vitro confirming their anti-secretory activity. In conclusion, xyloccensin-E and xyloccensin-I were found to possess anti-ulcerogenic activity which might be due to their anti-secretory activity and subsequent strengthening of the defensive mechanism.
- Open Access
- 3 August 2014
- Published by Springer Nature in Natural Products and Bioprospecting
- Vol. 4 (5) , 277-283
A New Gastroprotective Effect of Limonoid Compounds Xyloccensins X and Y from Xylocarpus Molluccensis in Rats
Gastric ulcer is a very common gastrointestinal disorder affecting a large number of people worldwide. It arises due to an imbalance between aggressive (acid, pepsin and Helicobacter pylori infection) and protective (mucin secretion, prostaglandin, epidermal growth factors and bicarbonate) factors in the stomach. In this study, the gastroprotective activity has been investigated of the active constituents from Xylocarpus molluccensis. Antiulcer activity of xyloccensins X+Y was investigated and found to be active in various ulcer models in Sprague–Dawley (SD) rats. To understand the mechanism of action of active constituent of natural products, the effects of the compounds on antisecretory and cytoprotective activities were studied. Air dried fruits were extracted with ethanol and fractionated into four fractions. Xyloccensins X+Y were isolated from the active fraction and was tested against different ulcer models. Xyloccensins X+Y were found to possess anti-ulcerogenic activity. The antiulcer activity might be due to its anti-secretory activity and subsequent strengthening of the defensive mechanism. The present study has helped us in identifying a new lead in the form of xyloccensins that could be exploited in the treatment of gastric ulcer disease.
- 3 August 2014
- Published by Springer Nature in Natural Products and Bioprospecting
- Vol. 4 (5) , 277-283
Open AccessA New Gastroprotective Effect of Limonoid Compounds Xyloccensins X and Y from Xylocarpus Molluccensis in Rats
Gastric ulcer is a very common gastrointestinal disorder affecting a large number of people worldwide. It arises due to an imbalance between aggressive (acid, pepsin and Helicobacter pylori infection) and protective (mucin secretion, prostaglandin, epidermal growth factors and bicarbonate) factors in the stomach. In this study, the gastroprotective activity has been investigated of the active constituents from Xylocarpus molluccensis. Antiulcer activity of xyloccensins X+Y was investigated and found to be active in various ulcer models in Sprague–Dawley (SD) rats. To understand the mechanism of action of active constituent of natural products, the effects of the compounds on antisecretory and cytoprotective activities were studied. Air dried fruits were extracted with ethanol and fractionated into four fractions. Xyloccensins X+Y were isolated from the active fraction and was tested against different ulcer models. Xyloccensins X+Y were found to possess anti-ulcerogenic activity. The antiulcer activity might be due to its anti-secretory activity and subsequent strengthening of the defensive mechanism. The present study has helped us in identifying a new lead in the form of xyloccensins that could be exploited in the treatment of gastric ulcer disease.
- 17 December 2013
- Published by Springer Nature in Journal of Natural Medicines
- Vol. 68 (2) , 363-371
Antidyslipidemic effect and antioxidant activity of anthraquinone derivatives from Rheum emodi rhizomes in dyslipidemic rats
The aim of the present study was to evaluate the antidyslipidemic effect of ethanolic extract of Rheum emodi rhizomes and its constituents in Triton-WR-1339 and high-fat diet (HFD)-induced dyslipidemic rats. In preliminary screening, the ethanolic extract showed significant activity in Triton-treated rats. Bioassay-guided fractionation of the ethanolic extract resulted in the identification of four anthraquinone derivatives, viz. chrysophanol, emodin, chrysophanol 8-O-β-d-glucopyranoside and emodin 8-O-β-d-glucopyranoside as active constituents. All these compounds significantly reduced plasma lipid levels. The most active compound emodin showed significant lipid-lowering activity in the HFD-fed model. In addition, these compounds showed significant antioxidant activity. The effect of emodin on enzymes modulating lipid metabolism confirms and supports the efficiency of emodin as a potent antidyslipidemic agent.
- 17 December 2013
- Published by Springer Nature in Journal of Natural Medicines
- Vol. 68 (2) , 363-371
Antidyslipidemic effect and antioxidant activity of anthraquinone derivatives from Rheum emodi rhizomes in dyslipidemic rats
The aim of the present study was to evaluate the antidyslipidemic effect of ethanolic extract of Rheum emodi rhizomes and its constituents in Triton-WR-1339 and high-fat diet (HFD)-induced dyslipidemic rats. In preliminary screening, the ethanolic extract showed significant activity in Triton-treated rats. Bioassay-guided fractionation of the ethanolic extract resulted in the identification of four anthraquinone derivatives, viz. chrysophanol, emodin, chrysophanol 8-O-β-d-glucopyranoside and emodin 8-O-β-d-glucopyranoside as active constituents. All these compounds significantly reduced plasma lipid levels. The most active compound emodin showed significant lipid-lowering activity in the HFD-fed model. In addition, these compounds showed significant antioxidant activity. The effect of emodin on enzymes modulating lipid metabolism confirms and supports the efficiency of emodin as a potent antidyslipidemic agent.
Antidyslipidemic and Antioxidant Effects of Novel Lupeol‐Derived Chalcones
A series of Lupeol‐based chalcones have been synthesized aiming to enhance the therapeutic efficacy of parent compound, the novel compounds were evaluated for their antidyslipidemic activity in triton‐WR 1339 induced hyperlipidemic rats. Among the ten synthesized chalcones, the most active K4, K8, and K9 reversed the plasma levels of TC by (24, 25, 27 %), phospholipid by (25, 26, 25 %) and triacylglycerol by (27, 24, 24 %) respectively. In addition, the compounds showed significant in vitro antioxidant activity. The lipid lowering activity of these compounds were mediated through lipoprotein lipase activation (12–21 %) and enhanced post‐heparin lipolytic activity (15–16 %). The compounds also displayed noteworthy inhibitory effect on 3‐hydroxy‐3‐methyl‐glutaryl reductase activity (in vitro). The in vitro effect of the most active compounds on MDI‐induced adipogenesis using 3T3‐L1 preadipocytes at 10 and 20 μM concentrations showed significant inhibition (20–32 %) of adipogenesis.
Antidyslipidemic and Antioxidant Effects of Novel Lupeol‐Derived Chalcones
A series of Lupeol‐based chalcones have been synthesized aiming to enhance the therapeutic efficacy of parent compound, the novel compounds were evaluated for their antidyslipidemic activity in triton‐WR 1339 induced hyperlipidemic rats. Among the ten synthesized chalcones, the most active K4, K8, and K9 reversed the plasma levels of TC by (24, 25, 27 %), phospholipid by (25, 26, 25 %) and triacylglycerol by (27, 24, 24 %) respectively. In addition, the compounds showed significant in vitro antioxidant activity. The lipid lowering activity of these compounds were mediated through lipoprotein lipase activation (12–21 %) and enhanced post‐heparin lipolytic activity (15–16 %). The compounds also displayed noteworthy inhibitory effect on 3‐hydroxy‐3‐methyl‐glutaryl reductase activity (in vitro). The in vitro effect of the most active compounds on MDI‐induced adipogenesis using 3T3‐L1 preadipocytes at 10 and 20 μM concentrations showed significant inhibition (20–32 %) of adipogenesis.
- 1 March 2013
- Published by Insight Knowledge in Pharmacologia
- Vol. 4 (3) , 243-248
Vincamine and Vindoline from Catharanthus roseus linn. Protects the Gastric Mucosa of Gastric Ulcer in Rats
- 1 March 2013
- Published by Insight Knowledge in Pharmacologia
- Vol. 4 (3) , 243-248
Vincamine and Vindoline from Catharanthus roseus linn. Protects the Gastric Mucosa of Gastric Ulcer in Rats
- 1 February 2013
- Published by Insight Knowledge in Pharmacologia
- Vol. 4 (2) , 132-137
A Potent Neurotoxic Effect of the Methanolic Extract of the Parazoanthus Mediated by NMDA Receptors
- 1 February 2013
- Published by Insight Knowledge in Pharmacologia
- Vol. 4 (2) , 132-137
A Potent Neurotoxic Effect of the Methanolic Extract of the Parazoanthus Mediated by NMDA Receptors
- 1 May 2012
- Published by Taylor & Francis in Natural Product Research
- Vol. 26 (10) , 913-918
Antifungal activity of bivittoside-D fromBohadschia vitiensis (Semper)
This study was carried out to investigate the antifungal activity of Bohadschia vitiensis Semper whole body extracts, followed by isolation and characterisation of bioactive molecules. The methanol extract of the B. vitiensis showed promising activity in in vitro models against Candida albicans, Cryptococcus neoformans, Sporothrix schenckii, Trichophyton mentagrophytes, Aspergillus fumigatus and Candida parapsilosis. The antifungal activity was found in aqueous fraction against C. albicans, C. neoformans, S. schenckii, T. mentagrophytes and A. fumigatus. The major compound was purified from the aqueous fraction and was identified as bivittoside-D isolated earlier from the animal. It showed promising results against C. neoformans, C. neoformans, S. schenckii, T. mentagrophytes, A. fumigatus and C. parapsilosis.
- 1 May 2012
- Published by Taylor & Francis in Natural Product Research
- Vol. 26 (10) , 913-918
Antifungal activity of bivittoside-D fromBohadschia vitiensis (Semper)
This study was carried out to investigate the antifungal activity of Bohadschia vitiensis Semper whole body extracts, followed by isolation and characterisation of bioactive molecules. The methanol extract of the B. vitiensis showed promising activity in in vitro models against Candida albicans, Cryptococcus neoformans, Sporothrix schenckii, Trichophyton mentagrophytes, Aspergillus fumigatus and Candida parapsilosis. The antifungal activity was found in aqueous fraction against C. albicans, C. neoformans, S. schenckii, T. mentagrophytes and A. fumigatus. The major compound was purified from the aqueous fraction and was identified as bivittoside-D isolated earlier from the animal. It showed promising results against C. neoformans, C. neoformans, S. schenckii, T. mentagrophytes, A. fumigatus and C. parapsilosis.
- 6 October 2010
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 20 (9) , 1622-1626
Lipid lowering and antioxidant activity of flavones in triton treated hyperlipidemic rats
- 6 October 2010
- Published by Springer Nature in Medicinal Chemistry Research
- Vol. 20 (9) , 1622-1626
Lipid lowering and antioxidant activity of flavones in triton treated hyperlipidemic rats
- 10 July 2009
- Published by Taylor & Francis in Natural Product Research
- Vol. 23 (10) , 963-972
Structure and activities of a steroidal saponin from Chlorophytum nimonii (Grah) Dalz
A new steroidal saponin, chloragin (1), was isolated and characterised from the aerial part of Chlorophytum nimonii. The structure of chloragin (1) was established as tigogenin-3-O-α-L-rhamnopyranosyl-(1 → 4)-β-D-glucopyranosyl-(1 → 3)-β-D-xylopyranosyl-(1 → 4)-β-D-glucopyranosyl-(1 → 4)-β-D-xyloopyranoside on the basis of detailed chemical and spectral evidence. The saponin showed potent antihyperglycaemic and antidyslipidaemic activities in albino rats.
- 10 July 2009
- Published by Taylor & Francis in Natural Product Research
- Vol. 23 (10) , 963-972
Structure and activities of a steroidal saponin from Chlorophytum nimonii (Grah) Dalz
A new steroidal saponin, chloragin (1), was isolated and characterised from the aerial part of Chlorophytum nimonii. The structure of chloragin (1) was established as tigogenin-3-O-α-L-rhamnopyranosyl-(1 → 4)-β-D-glucopyranosyl-(1 → 3)-β-D-xylopyranosyl-(1 → 4)-β-D-glucopyranosyl-(1 → 4)-β-D-xyloopyranoside on the basis of detailed chemical and spectral evidence. The saponin showed potent antihyperglycaemic and antidyslipidaemic activities in albino rats.